Lee, Danner & Bass’s Thermo Fisher Scientific TMO Stock Holding History

Lee, Danner & Bass’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-116	Closed	-$60.3K	–	658
2024 Q4	$60.3K	Buy	+116	New	+$63.8K	﹤0.01%	329

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lee, Danner & Bass's TMO Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 116 shares — an estimated $60.3K sold.

Lee, Danner & Bass first reported a position in TMO in Q4 2024 and held it in 1 quarter. The position peaked at $60.3K in Q4 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Lee, Danner & Bass reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 116 Thermo Fisher Scientific shares in Q1 2025, an estimated $60.3K.
Lee, Danner & Bass first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Thermo Fisher Scientific position peaked at $60.3K in Q4 2024.
2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.